Cardiol Therapeutics (CRDL)
Develops oral and injectable therapies for inflammatory heart disease.
$1.74
vs last close−0.15 (−8.05%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 25.61% | 29.52M shares | |
|---|---|---|---|
| 55 holders · as of Jun 30, 2026 | |||
| Other | 74.39% | 85.76M shares | |
| remainder | |||
115.27M company shares as of Aug 27, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
55 holders · 29.52M shares · 12 new positions · 23 increased · 11 reduced · 5 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Mmcap International Inc. SPC | 15.60M | 13.53% | +246.2K | Aug 14, 2026 |
| Tejara Capital Ltd | 5.11M | 4.44% | −16.3K | Aug 11, 2026 |
| Ikarian Capital, LLC | 3.33M | 2.88% | +600.0K | Aug 14, 2026 |
| Boothbay Fund Management, LLC | 975.7K | 0.85% | +180.8K | Aug 14, 2026 |
| Citadel Advisors LLC | 796.5K | 0.69% | −23.4K | Sep 2, 2026 |
| Renaissance Technologies LLC | 772.8K | 0.67% | +543.0K | Aug 13, 2026 |
| Two Sigma Investments, LP | 746.9K | 0.65% | +212.7K | Aug 14, 2026 |
| Brokers International Financial Services, LLC. | 388.5K | 0.34% | −76.5K | Jul 31, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| MMCAP International Inc. SPC | 17.90% | 21.06M | 13G | May 15, 2026 |
| Tejara Capital Ltd | 5.20% | 5.13M | 13G | Oct 23, 2025 |
Form 4
Latest trades
Nothing filed in the last 12 months.
House and Senate disclosures
Not reported.